<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61552</article-id><article-id pub-id-type="doi">10.7554/eLife.61552</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-200702"><name><surname>Yang</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-200703"><name><surname>Hughes</surname><given-names>Thomas A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7887-6876</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-200704"><name><surname>Kelkar</surname><given-names>Anju</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-200705"><name><surname>Yu</surname><given-names>Xinheng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210967"><name><surname>Cheng</surname><given-names>Kai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76883"><name><surname>Park</surname><given-names>Sheldon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200706"><name><surname>Huang</surname><given-names>Wei-Chiao</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200707"><name><surname>Lovell</surname><given-names>Jonathan F</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9052-884X</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-55154"><name><surname>Neelamegham</surname><given-names>Sriram</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1371-8500</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf5"/></contrib><aff id="aff1"><institution content-type="dept">Department of Chemical and Biological Engineering</institution>, <institution>State University of New York at Buffalo</institution>, <addr-line><named-content content-type="city">Buffalo</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Biomedical Engineering</institution>, <institution>State University of New York at Buffalo</institution>, <addr-line><named-content content-type="city">Buffalo</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-31284"><name><surname>McConville</surname><given-names>Malcolm J</given-names></name><role>Reviewing editor</role><aff><institution>The University of Melbourne</institution>, <country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>neel@buffalo.edu</email> (SN);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>26</day><month>10</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e61552</elocation-id><history><date date-type="received"><day>29</day><month>07</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Yang et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Yang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61552-v1.pdf"/><abstract><p>The Spike protein of SARS-CoV-2, its receptor binding domain (RBD), and its primary receptor ACE2 are extensively glycosylated. The impact of this post-translational modification on viral entry is yet unestablished. We expressed different glycoforms of the Spike-protein and ACE2 in CRISPR-Cas9 glycoengineered cells, and developed corresponding SARS-CoV-2 pseudovirus. We observed that N- and O-glycans had only minor contribution to Spike-ACE2 binding. However, these carbohydrates played a major role in regulating viral entry. Blocking N-glycan biosynthesis at the oligomannose stage using both genetic approaches and the small molecule kifunensine dramatically reduced viral entry into ACE2 expressing HEK293T cells. Blocking O-glycan elaboration also partially blocked viral entry. Mechanistic studies suggest multiple roles for glycans during viral entry. Among them, inhibition of N-glycan biosynthesis enhanced Spike-protein proteolysis. This could reduce RBD presentation on virus, lowering binding to host ACE2 and decreasing viral entry. Overall, chemical inhibitors of glycosylation may be evaluated for COVID-19.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HL103411</award-id><principal-award-recipient><name><surname>Neelamegham</surname><given-names>Sriram</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM133195</award-id><principal-award-recipient><name><surname>Neelamegham</surname><given-names>Sriram</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM126537</award-id><principal-award-recipient><name><surname>Neelamegham</surname><given-names>Sriram</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM139160</award-id><principal-award-recipient><name><surname>Park</surname><given-names>Sheldon</given-names></name><name><surname>Neelamegham</surname><given-names>Sriram</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Qi Yang, Co-author of a provisional patent application.(63/079,667).</p></fn><fn fn-type="conflict" id="conf3"><p>Thomas A Hughes, Co-author of a provisional patent application.(63/079,667).</p></fn><fn fn-type="conflict" id="conf4"><p>Anju Kelkar, Co-author of a provisional patent application.(63/079,667).</p></fn><fn fn-type="conflict" id="conf5"><p>Sriram Neelamegham, Co-author of a provisional patent application.(63/079,667).</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. All plasmids generated by the authors will be deposited at Addgene.</p></sec><supplementary-material><ext-link xlink:href="elife-61552-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>